We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$49.9B
AUM Growth
+$3.67B
Cap. Flow
+$2.03B
Cap. Flow %
4.06%
Top 10 Hldgs %
18.48%
Holding
3,585
New
248
Increased
1,827
Reduced
1,181
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 9.37%
2 Financials 8.94%
3 Healthcare 8.86%
4 Industrials 6.89%
5 Communication Services 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URA icon
2801
Global X Uranium ETF
URA
$6.22B
$290K ﹤0.01%
+21,767
New +$300K
UTHR icon
2802
United Therapeutics
UTHR
$23.1B
$290K ﹤0.01%
2,473
-1,661
-40% -$212K
BOX icon
2803
Box
BOX
$4.6B
$289K ﹤0.01%
14,962
+3,665
+32% +$68.9K
SYBT icon
2804
Stock Yards Bancorp
SYBT
$2.6B
$289K ﹤0.01%
7,602
+787
+12% +$28.3K
PRTK
2805
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$289K ﹤0.01%
+11,525
New +$268K
MORN icon
2806
Morningstar
MORN
$7.53B
$288K ﹤0.01%
3,386
+88
+3% +$7.17K
EIV
2807
DELISTED
Eaton Vance Municipal Bond Fund II
EIV
$288K ﹤0.01%
22,922
+209
+0.9% +$2.66K
SWP
2808
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
$287K ﹤0.01%
2,500
CNDT icon
2809
Conduent
CNDT
$264M
$286K ﹤0.01%
18,283
-2,497
-12% -$40.8K
AMRN
2810
Amarin Corp
AMRN
$303M
$285K ﹤0.01%
4,070
-200
-5% -$14.2K
CBAY
2811
DELISTED
Cymabay Therapeutics
CBAY
$285K ﹤0.01%
+35,300
New +$239K
AJRD
2812
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$285K ﹤0.01%
+8,144
New +$219K
IMO icon
2813
Imperial Oil
IMO
$60.4B
$282K ﹤0.01%
8,833
-3,855
-30% -$115K
KTOS icon
2814
Kratos Defense & Security Solutions
KTOS
$11.4B
$282K ﹤0.01%
+21,529
New +$265K
ENSG icon
2815
The Ensign Group
ENSG
$10.7B
$281K ﹤0.01%
13,293
-1,024
-7% -$20.1K
HDP
2816
DELISTED
Hortonworks, Inc.
HDP
$281K ﹤0.01%
16,600
+1,000
+6% +$15.1K
COKE icon
2817
Coca-Cola Consolidated
COKE
$12.8B
$279K ﹤0.01%
+12,910
New +$285K
FRBA icon
2818
First Bank
FRBA
$454M
$279K ﹤0.01%
21,007
MFG icon
2819
Mizuho Financial
MFG
$130B
$278K ﹤0.01%
78,329
+10,855
+16% +$38.1K
NAZ icon
2820
Nuveen Arizona Quality Municipal Income Fund
NAZ
$158M
$277K ﹤0.01%
18,927
GNBC
2821
DELISTED
Green Bancorp, Inc
GNBC
$277K ﹤0.01%
11,726
FDRR icon
2822
Fidelity Dividend ETF for Rising Rates
FDRR
$761M
$276K ﹤0.01%
+9,495
New +$271K
NVMI
2823
Nova
NVMI
$12.5B
$276K ﹤0.01%
+9,816
New +$239K
LIT icon
2824
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$275K ﹤0.01%
+7,354
New +$243K
TRST
2825
Trustco Bank Corp NY
TRST
$938M
$275K ﹤0.01%
6,171

Similar funds

Raymond James & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Raymond James & Associates held 3,585 positions worth $49.9B, up 7.9% from $46.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.03B of net new capital in Q3 2017, opening 248 new positions and adding to 1,827 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 9.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $61.8M trimmed.

  • Raymond James & Associates's largest Q3 2017 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2017, an estimated $261M increase.
  • Raymond James & Associates's biggest Q3 2017 reduction was McDonald's, cutting an estimated $61.8M.
  • Raymond James & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $69.8M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $49.9B portfolio in Q3 2017.
  • Raymond James & Associates opened 248 new positions and closed 188 in Q3 2017.
  • Raymond James & Associates's portfolio value rose 7.9% quarter-over-quarter to $49.9B.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.